Morgan Joseph

 

 

 
Financial Restructuring
 

 
business services
 
consumer & leisure
 
healthcare
 
benefits mgt
 
healthcare facilities
 
healthcare IT
 
life science
 
medtech, devices & supplies
 
providers & other services
 indsutrial

 
tmt
 
international practice
 other

 
 
International Practice
 

 
Contact Us
 
 

Sector Coverage

Biotechnology

Antisense / RNAi
Gene Therapy
Monoclonal Antibodies
Recombinant Proteins
Stem Cells
Therapeutic Vaccines

Drug Delivery

Life Science Tools & Services

Drug Discovery
Genomics / Protemoics
Molecular Diagnostics

Nutraceuticals

Specialty Pharmaceuticals

Recent Transactions

Morgan Joseph acted as co-managing underwriter in connection with the
initial public offering by Cumberland Pharmaceuticals Inc.
Morgan Joseph acted as co-managing underwriter in connection with the
offering of common stock by ImmunoGen, Inc.
Morgan Joseph acted as financial advisor in connection with the
registered direct offering by Spectrum Pharmaceuticals, Inc.
Morgan Joseph acted as financial advisor in connection with the
registered direct offering by Spectrum Pharmaceuticals, Inc.
Morgan Joseph served as a co-placement agent in connection with the registered direct offering by Lev Pharmaceuticals Inc.
Morgan Joseph served as a co-manager in connection with the follow-on offering of common stock by Arena Pharmaceuticals, Inc.
Morgan Joseph served as a financial advisor in connection with the sale of the Preclinical Division of Gene Logic Inc. to Bridge Pharmaceuticals Inc.
 
 
 



Copyright © 2010 Morgan Joseph & Co. Inc.



Contact Information

Michael J. Innes
Managing Director
New York
212.218.3789
minnes@mjco.com

Mitchell S. Stern
Managing Director
New York
212.218.3839
mstern@morganjoseph.com

Jill S. Steier
Managing Director
New York
212.218.3726
jsteier@mjco.com

Michael Holland
Vice President
Miami
305.459.1443
mholland@morganjoseph.com